tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Onconetix Announces 2025 Annual Meeting Details

Story Highlights
  • Onconetix will hold its 2025 annual stockholders meeting on December 5, 2025.
  • Shareholder proposals and director nominations are due by November 10, 2025, for inclusion in proxy materials.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Onconetix Announces 2025 Annual Meeting Details

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Onconetix ( (ONCO) ) just unveiled an announcement.

On October 23, 2025, Onconetix, Inc.’s Board of Directors decided to hold the 2025 annual meeting of stockholders on December 5, 2025, at the offices of Ellenoff Grossman & Schole LLP in New York. The company announced that shareholder proposals and director nominations for the meeting must be submitted by November 10, 2025, to be included in the proxy materials, in compliance with applicable regulations.

Spark’s Take on ONCO Stock

According to Spark, TipRanks’ AI Analyst, ONCO is a Underperform.

Onconetix’s overall score reflects substantial financial difficulties with significant operating losses and negative profitability metrics. The technical analysis suggests a bearish trend, and the valuation metrics are unfavorable due to negative earnings. These factors combine to give the stock a low attractiveness score.

To see Spark’s full report on ONCO stock, click here.

More about Onconetix

Average Trading Volume: 555,897

Technical Sentiment Signal: Sell

Current Market Cap: $5.53M

Learn more about ONCO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1